-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Intercept Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2012 to Q1 2023.
- Intercept Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$51.6M, a 156% decline year-over-year.
- Intercept Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$26.8M, a 34.8% increase from 2021.
- Intercept Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$41.1M, a 76.1% increase from 2020.
- Intercept Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$172M, a 27.4% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)